We're collaborating with start-ups who have a potential solution for COVID-19 through our innovative risk-sharing models and funding opportunities.
EPA and OSHA approved to use against SARS-CoV-2 (COVID-19) and influenza viruses. Kills 99.9% of viruses and bacteria, as well as mildew and mold. Made in the USA
Our leaders and executive teams from MediSci are taking actions to assist at the state level and central governments to act quickly to consider all potential consequences and to implement solutions before it occurs. COVID-19 is adversely impacting health worldwide and motivating significant social and economic responses. We are using our resources to build a team to support all patients with or without insurance, provide a 24/7 nursing helpline, offer the COVID-19 test, provide remote monitoring, and dispatch medical care packages to affected patients.
Minimizing transmission: Providing COVID-19 PCR and antibody test for the front line healthcare and essential personnel.
Patient App: Biometric and symptoms reporting integrated with point of care and 24/7 nursing line.
EUA approved trials for drugs and devices used for outpatient treatment of
MediSci's ACT Program is a collaboration with the San Diego Public Health Department and LabCorp to provide COVID-19 test for the front line healthcare and essential personnel working with high-risk patients.
(Asymptomatic COVID-19 Test)
The Complete Research Optimizing System (C.R.O.S), a patient-centered platform developed with centralized blockchain technology provided by AWS (QLDB) developed by MediSci, which enhances, and supports healthcare and medical product development. C.R.O.S improves both the quality of care and outcomes at a reduced cost.
We're reimagining Healthcare. Increasing patient engagement with interactive IoT devices, drug event reporting, health surveys, Management of secure medical information, and health-related micropayment transactions.
Using centralized blockchain technology (QLDB), our product provides a custom ecosystem that is secure, immutable and, effectively analyzes data to predict real-time outcomes, automate rule-based workflow, customize medication treatments, and target evidence-based care plans.
Increase patient engagement with continuous biometric monitoring, symptoms reporting, health rewards program, and 24/7 access to care.
Our goal is to improve health and reduce the cost of medical care through Early Detection, Prevention, Coordinated Care, Evidence-Based Care, Better Patient Experience, and Improved Efficiency. These C.R.O.S enhancements aim to improve patient access to healthcare and increase the quality of care.
Transforming healthcare through a complete digitalized patient-centric platform, bringing technology to the frontline for a better health outcome for every patient.
The members of the MediSci team are motivated individuals who came together to pursue a common mission: